SCHEMBL29360640

SCHEMBL29360640

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.64
NR5A2 O00482 1/20 0.64
NR5A1 Q13285 1/20 0.64
LPAR1 Q92633 6/20 0.62
ENPP2 Q13822 2/20 0.62
LPAR4 Q99677 2/20 0.62
LPAR5 Q9H1C0 2/20 0.62
LPAR2 Q9HBW0 2/20 0.62
LPAR3 Q9UBY5 2/20 0.62
CES2 O00748 1/20 0.62
LPAR6 P43657 1/20 0.62
TRPV1 Q8NER1 1/20 0.62
MAPT P10636 1/20 0.62
MEN1 O00255 1/20 0.58
S1PR1 P21453 1/20 0.58
KMT2A Q03164 1/20 0.58
P2RY10 O00398 3/20 0.55
GPR174 Q9BXC1 3/20 0.55
GPR34 Q9UPC5 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26642826 1.00 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL26642821 1.00 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL31596828 1.00 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL19821339 0.97 SMN1; SMN2 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL17626959 0.97 SMN1; SMN2 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL31577378 0.97 SMN1; SMN2 (0.68) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL38651811 0.95 LPAR1 (0.66) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL25700292 0.94 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL31463311 0.94 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1
SCHEMBL19864320 0.93 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2NR5A2NR5A1LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731002-A2 SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS Tenfold Technologies, LLC (US) 2026-04-29 EP claimed
EP-4627352-A1 DIAGNOSIS OF METABOLIC CHANGES OF THE LIVER BY WAY OF METABOLIC ANALYSIS OF ERYTHROCYTES BY MASS SPECTROMETRY Universitätsklinikum Jena (DE) 2025-10-08 EP claimed
US-20250306042-A1 METHOD FOR DIAGNOSING ENDOMETRIOSIS IN A SUBJECT UNIV LJUBLJANI (SI) 2025-10-02 US claimed
WO-2025121905-A1 BIOMARKER FOR DIAGNOSING RENAL CELL CARCINOMA AND USE THEREOF 국립암센터 2025-06-12 WO claimed
WO-2025091079-A1 DIAGNOSTIC SIGNATURE BCAL Diagnostics Limited (AU) 2025-05-08 WO claimed
CN-119534850-A Marker group capable of reflecting prolongation of post-PCI proinflammatory period of ACS patient and application thereof 天津中医药大学 2025-02-28 CN claimed
CN-113396332-B Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof 斯坦福大学托管董事会 2025-02-11 CN claimed
EP-4490520-A1 METHOD FOR DIAGNOSING ENDOMETRIOSIS IN A SUBJECT Univerza V Ljubljani (SI) 2025-01-15 EP claimed
WO-2024263793-A2 SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS Tenfold Technologies, LLC (US) 2024-12-26 WO claimed
US-20240361326-A1 EXOSOMAL LIPIDS AND METABOLITES FOR THE EARLY DETECTION OF HEPATOCELLULAR CARCINOMA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-10-31 US claimed
US-11506665-B2 Metabolic biomarker set for assessing ovarian cancer BIOCRATES LIFE SCIENCES AG (AT) 2022-11-22 US claimed
US-20220308075-A1 LIPID PROFILING METHODS FOR PREDICTING POSITIVE PREGNANCY OUTCOME HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (IL) 2022-09-29 US claimed
CN-110178035-B Type 2 diabetes marker and application thereof 深圳华大生命科学研究院 2022-09-23 CN claimed
CN-110199198-B Metabolic biomarker panels for assessing ovarian cancer 生物速率生命科学股份公司 2022-09-06 CN claimed
US-20220187315-A1 METHODS AND COMPOSITIONS FOR DIAGNOSING DEPRESSION DUKE UNIVERSITY 2022-06-16 US claimed
EP-3987290-A1 SERIES OF METABOLITES AS BIOMARKERS FOR THE DIAGNOSIS OF PANCREATIC CANCER Universidad de Granada (ES) 2022-04-27 EP claimed
US-11313866-B2 Method of diagnosing and treating asphyxia INFANDX AG (DE) 2022-04-26 US claimed
CN-109596748-B Method for detecting metabolites of gandi capsules for treating diabetic nephropathy patients 上海交通大学医学院附属新华医院 2022-03-04 CN claimed
WO-2022026922-A2 METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES GENENTECH, INC. (US) 2022-02-03 WO claimed
CN-111122757-B Metabonomics-based research method for bee toxicity effect caused by date flower honey 山西大学 2022-01-28 CN claimed